Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells
Abstract Background Small cell lung cancer (SCLC) is the most malignant lung cancer type. Due to the high rates of metastasis and drug resistance, effective therapeutic strategies remain lacking. Tanshinone IIA (Tan IIA) has been reported to exhibit anti-tumor activity. Therefore, this study investi...
Main Authors: | Yuxin Jiang, Yanli Bi, Lingjie Zhou, Senwen Zheng, Tingting Jian, Jian Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-024-04363-y |
Similar Items
-
Tanshinone IIA inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway
by: Hu Li, et al.
Published: (2015-06-01) -
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
by: Xifeng Zhai, et al.
Published: (2017-01-01) -
Evaluation of Tanshinone IIA Developmental Toxicity in Zebrafish Embryos
by: Tao Wang, et al.
Published: (2017-04-01) -
Renoprotective Effects of Tanshinone IIA: A Literature Review
by: Zhengtao Chen, et al.
Published: (2023-02-01) -
Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
by: Chengdong Qin, et al.
Published: (2023-06-01)